AMSBIO is a leading supplier of high-resolution exosomes using isolation techniques, including traditional differential and gradient ultracentrifugation, immunoaffinity, size exclusion chromatography, as well as precipitation / low speed centrifugation.
Exosomes are a small endosome derived lipid nanoparticles that are actively secreted by exocytosis in most living cells. Exosomes are able to be released either constitutively or upon induction, in a controlled, functional manner. Exosomes have pleiotropic physiological and pathological characteristics and are effective in diverse pathological conditions such as cancer and infectious and neurodegenerative diseases.
AMSBIO, which is based on a rich history, offers a wide range of service options for exosome isolation and characterization.
AMSBIO offers a service to extract RNA from exosomes and subject it to RNA-Sequencing using an Illumina platform. Outside basic screening for specific miRNA can be provided by AMSBIO.
AMSBIO also offers a superior-quality service that allows for a reliable and reproducible extraction of exosomes from almost any biofluid, from plasma and tissue culture media to cerebrospinal fluid. Using this service, your target exosomes are separated by ultracentrifugation before quantification and quality assessment using a NanoDrop spectrophotometer.